489 Full
489 Full
489 Full
6, 2009
Toyohashi, Japan
The aim of this study was to examine the procedural success and in-hospital outcomes after percuta-
neous coronary intervention (PCI) for chronic total occlusions in the current era during contemporary
practice. The technique of PCI has improved over time with the introduction of novel equipment and
guidewire crossing techniques. However, there is limited data available from contemporary practice in
the recent years. We evaluated the procedural and in-hospital outcomes in a consecutive series of 904
procedures performed at Toyohashi Heart Center for PCI of chronic total occlusions of 3 months in
duration. Technical and procedural success was achieved in 87.5% and 86.2%, respectively. In-hospital
major adverse cardiac events occurred in only 1.9% of the patients. Single antegrade wire was the pre-
dominant strategy for guidewire crossing; however, retrograde guidewire crossing was used in 7.2% of
the cases and controlled antegrade and retrograde subintimal tracking in 9.9% of the cases as the nal
strategy. Logistic regression analysis identied severe tortuosity and moderate-to-severe calcication as
signicant predictors of procedural failure. This is the rst reported large series of patients undergoing
PCI for chronic total occlusion with improved wire crossing techniques. We have reported high success
rates in recent years and very low complication rates despite the use of more aggressive devices and
techniques. (J Am Coll Cardiol Intv 2009;2:489 97) 2009 by the American College of Cardiology
Foundation
Percutaneous coronary intervention (PCI) of failure to cross the lesion with the guidewire
chronic total occlusion (CTO) is considered a (4 11). Recent development of dedicated guide-
major frontier in interventional cardiology. Ap- wires, sophisticated technologies, and increasing
proximately one-third to one-half of patients with clinical experience and skills have improved the
significant coronary artery disease on angiography procedural outcomes with CTO-PCI. Moreover,
have at least 1 CTO (1,2). However, they account the novel methods of guidewire crossing particu-
for only 10% to 15% of all PCI activity (3), and the larly parallel wire, retrograde, and controlled ante-
majority of the patients are treated with either grade and retrograde subintimal tracking (CART)
coronary artery bypass grafting or medical therapy. techniques have given much hope for the treatment
The procedural success rate for CTO has improved of chronically occluded arteries.
over time, but is still low and is mainly due to the However, there is limited data on the procedural
success rate and procedural complications with
these techniques after PCI for CTO in contempo-
From the Department of Cardiology, Toyohashi Heart Center, Toyo- rary practice. Several previous large studies have
hashi, Japan.
shown procedural success rates and outcomes after
Manuscript received February 17, 2009; revised manuscript received
April 6, 2009, accepted April 17, 2009. CTO-PCI, but they have also included the pa-
490 Rathore et al. JACC: CARDIOVASCULAR INTERVENTIONS, VOL. 2, NO. 6, 2009
tients with recent occlusions (10) and all occlusions of more Procedure time is defined as the time difference between
than 1 months duration (3,12,13). the patients entry and exit from the catheterization room.
The aim of our study is to analyze the procedural success Fluoroscopy time and dosing data was available in only 350
rates, guidewire strategies, and in-hospital outcomes in the patients. Type 1 coronary perforation was defined as discrete
patients treated for CTO-PCI in contemporary practice. or localized extravasation of the contrast medium and Type
2 coronary perforation was defined as persistent visible
Methods extravasation of the contrast medium.
Interventional technique and guidewire crossing strategies.
Study design. Consecutive patients who underwent PCI of The operators performed the PCI procedure according to
a chronic occluded artery were identified from the dedicated their practice at that time, and most of the procedures were
database at the Toyohashi Heart Center, Toyohashi, Japan, performed via femoral route using 8-F guiding catheters.
where data was entered prospectively. All procedures per-
The technique has been modified over time by routine use
formed between January 2002 and July 2008 were included
of bilateral simultaneous coronary injections and dedicated
in this analysis. The database includes demographic, clini-
stiff wires, including Xtreme (Asahi Intecc, Aichi, Japan),
cal, angiographic, and procedural data; guidewire strategies;
Fielder and Fielder FC (Asahi Intecc), Miracle 3-12 (Asahi
and in-hospital outcomes.
Denitions. Our study defined CTO as a lesion showing
Intecc), and stiff-tapered wires (Confianza Family, Asahi
Thrombolysis In Myocardial In- Intecc). Also, the uptake of micro catheters (Finecross MG,
Abbreviations farction (TIMI) flow grades of 0 Terumo Corporation, Tokyo, Japan) and over-the-wire
and Acronyms
to 1 that were 3 months or more specialist devices has increased over time.
CABG coronary artery in duration. All patients included The guidewire strategies used were single wire technique,
bypass surgery in this analysis had at least 1 parallel (contact) wire technique, intravascular ultrasound
CART controlled occlusive lesion. Duration of oc- (IVUS)-guided wiring technique, and retrograde wiring
antegrade and retrograde
clusion was estimated on the basis through collaterals and CART technique. These techniques
tracking
of either history of angina or pre- have been described by our group in the past (14 18).
CK creatinine kinase
vious myocardial infarction (MI) The sequence of these wiring techniques and selection of
CTO chronic total the guidewire is completely dependent on the operators
in the same territory or proven by
occlusion
previous angiography. discretion and the patients coronary anatomy. Generally the
IVUS intravascular
Major adverse cardiac events antegrade approach was started with a step up to different
ultrasound
(MACE) were defined as death, wiring strategies and stiffer wires depending on the progress.
MACE major adverse
cardiac events
Q-wave MI, or urgent revascu- Briefly, parallel wire (contact wire) technique involves 2
larization during the same ad- antegrade wires in which the first wire ends up in the false
MI myocardial infarction
mission. Urgent revasculariza- lumen. The shaft of second wire remains in contact with the
PCI percutaneous
coronary intervention
tion was defined as target vessel first wire and the tip is deflected to gain entry into the true
repeat PCI within 24 h or urgent lumen.
TIMI Thrombolysis In
Myocardial Infarction
coronary artery bypass surgery Intravascular ultrasound guided wiring was used when the
(CABG). entry point of the CTO was not visible, therefore IVUS was
Q-wave MI was defined as cardiac enzymes (creatinine
used to localize the entry point. Second, IVUS was used to
kinase [CK]) elevation of more than 3 times the normal
help find the true lumen in the event of guidewire entry into
value with development of Q-wave following the PCI.
the false lumen.
NonQ-wave MI was defined as elevation of CK greater
Retrograde wiring was used when favorable collaterals
than 3 times without development of Q-wave following the
were present and this technique involves manipulating and
PCI.
Technical success was defined as successful guidewire and advancing the guidewire into CTO retrogradely to reach the
balloon crossing with residual stenosis 50% and TIMI proximal true lumen and achieve successful recanalization.
flow grade 3. Procedural success was defined as residual The CART technique involves simultaneously antegrade
stenosis 50% with TIMI flow grade 3 without MACE. and retrograde guidewire manipulation using controlled
Acute occlusion is defined as target vessel occlusion antegrade and retrograde subintimal tracking to limit the
needing repeat PCI within 24 h. Subacute occlusion is extent of dissection to the CTO site and achieve successful
defined as target vessel occlusion needing repeat PCI within recanalization.
7 days. Side branch compromise was defined as TIMI flow All patients were treated with aspirin and thienopyridine
grades 0 to 1 in the side branch of 2.0 mm in size. (ticlopidine or clopidogrel) before the procedure and re-
Access-related complications were not included in this ceived heparin to achieve activated clotting time of around
analysis. 250 s.
JACC: CARDIOVASCULAR INTERVENTIONS, VOL. 2, NO. 6, 2009 Rathore et al. 491
JUNE 2009:489 97 Impact of Novel Guidewire Techniques
Statistical Analysis
Results
Table 1. Baseline Patient Demographics and Vessel Characteristics for CTO Success and Failure Groups
Table 2. Angiographic and Treatment Factors of CTO Success and Failure Groups
Target vessel
LAD 239 (30.2%) 28 (24.6%) NS
RCA 312 (39.3%) 43 (37.9%) NS
LCX 182 (23.1%) 19 (17.2%) NS
LMT 4 (0.4%) 1 (0.4%) NS
Branch 52 (6.6%) 22 (19.7%) 0.0001
RITA 1 (0.1%) 0 NS
SVG 1 (0.1%) 0 NS
Signicant side branch at CTO site 144 (18.2%) 11 (9.8%) 0.03
Calcication
None 240 (30.1%) 37 (31.5%) NS
Mild 258 (32.3%) 32 (28.5%) NS
Moderate 214 (26.9%) 22 (19.2%) 0.001
Severe 79 (9.9%) 22 (19.2%) NS
Ostial location 0.294
Aorto-ostial 10 (1.2%) 2 (1.4%)
Nonaorto-ostial 86 (10.9%) 17 (14.7%)
Nonostial 695 (87.8%) 94 (83.7%)
Tortuosity
None 675 (85.1%) 85 (75.3%) NS
Moderate 81 (10.5%) 16 (14.3%) NS
Severe 35 (4.4%) 12 (10.3%) 0.001
In-stent restenosis 95 (12.1%) 9 (8.3%) 0.174
Lesion length 30.53 13.68 24.72 6.01 0.067
Table 3. Patients Baseline, Procedural Characteristics, and Outcomes Comparing Different Wiring Strategies
Variables
Age, yrs 66.2 10.7 64.9 10.9 64.7 9.8 64.3 12.1 63.0 10.6 65.6 10.6 64.4 11.3 71.6 6.8 NS
Diabetes 40.8 38.2 42.2 31.9 42.9 33.3 40.2 42.9 NS
Male 79.5 85.2 84.5 87.4 84.1 82.2 83.9 71.4 NS
Hypertension 62.4 59.5 59.6 62.2 71.4 65.6 67.8 71.4 NS
Hyperlipidemia 37.8 41.8 40.4 41.5 42.9 42.2 47.1 28.6 NS
Smoking 24.9 31.7 31.1 33.3 28.6 28.9 32.2 20.0 NS
Previous MI 83.3 89.1 88.8 88.9 95.2 94.4 93.1 100 0.005
Previous CABG 10.1 15.8 12.4 13.3 19.0 21.1 18.4 40 0.041
Unstable angina 8.5 9.1 6.2 9.6 9.5 6.7 9.2 0 NS
Vessel
LAD 29.8 31.9 32.9 32.6 30.2 37.8 23 42.9 NS
RCA 35.9 43.4 38.5 48.9 50.8 51.1 65.5 51.1 0.0001
LCX 26.6 19.0 22.4 13.3 14.3 10.0 9.2 0 0.003
Branch 7.2 5.5 5.6 5.2 1.1 1.6 0 0 0.024
LMT 0.4 0.3 0.6 0 1.6 0 2.3 0 NS
Others 0.2 0 0 0 1.6 0 0 0 NS
Previous PCI 25.8 29.6 23.6 30.4 44.4 21.0 39.1 42.9 0.001
ISR 14.8 8.3 6.8 8.1 11.1 7.8 8.0 0 0.028
Side branch 18.6 14.5 19.9 11.9 20.6 15.6 14.9 0 NS
Tortuosity
Moderate 7.8 12.7 9.9 12.6 19.0 24.4 20.7 28.6 0.018
Severe 2.5 9.1 6.8 10.4 11.1 14.4 12.7 14.3 0.0001
Calcication
Moderate 24.3 27.8 33.5 23.7 19.0 32.2 34.5 14.3 0.0186
Severe 9.7 13.5 11.2 17.8 17.5 23.3 9.2 28.6
CTO length 31.1 13.7 27.8 12.46 26.4 13.4 36.5 15.0 34.6 14.5 27.3 5.06 31.4 11.8 N/A NS
Outcomes
Success rate 57.3% 54.5% 61.4% NS
Dissection 10.9 10.9 17.3 13.6 3.1 10 7.6 20 0.0183
Perforation
Type I 3.2 16.1 9.9 20.7 7.9 30.0 12.6 25 0.001
Type II 2 (0.4) 1 (0.3) 0 0 1 (1.6) 0 1 (1.1) 0
NonQ-wave MI 11 (2.1) 11 (2.9) 5 (3.1) 3 (1.9) 1 (1.6) 0 3 (3.4) 1 NS
Q-wave MI 1 (0.2) 4 (1.0) 2 (1.2) 1 (0.7) 0 0 0 0 NS
Cardiac tamponade 1 (0.2) 5 (1.3) 3 (1.9) 1 (0.7) 0 1 (1.1) 1 (1.1) 0 NS
Emergency CABG 1 (0.2) 1 (0.3) 0 0 0 1 (1.1) 0 0 NS
Death 2 (0.4) 3 (1.0) 0 3 (2.2) 0 0 0 0 NS
Procedure time, hh:mm 2.13 2.09 3.14 2.41 3.07 1.12 3.32 2.59 3.24 3.04 3.45 2.38 3.56 1.30 4.34 1.21 0.0001
Fluoroscopy time, mm:ss 59.57 34.40 100.00 49.03 80.16 40.32 114.00 53.50 101.60 48.10 112.40 48.71 112.96 52.29 135.32 26.29 0.0001
(n 350)
Fluoroscopy dose 7.65 5.31 11.81 8.39 10.17 6.92 13.05 10.84 12.25 6.67 14.50 8.55 12.65 6.19 13.21 15.23 0.0001
(frontal), Gy
(n 350)
Values are mean SD or %. Categorical variables presented as n (%) frequencies and continuous variables as mean SD. *p value compared between success in different groups; NS 0.05 (chi-square and
1-way analysis of variance). p 0.05 intragroup.
ISR in-stent restenosis; other abbreviations as in Tables 1 and 2.
artery in the retrograde technique success groups. However, patients. Single wire usage was the predominant strategy
the success rate with each wiring technique is similar, but used in 510 (64%) cases followed by parallel wire technique
overall, this increases the success rates cumulatively in some in 150 (19%) cases, retrograde guidewire crossing in 57 cases
494 Rathore et al. JACC: CARDIOVASCULAR INTERVENTIONS, VOL. 2, NO. 6, 2009
In-hospital complications. The in-hospital complications for Previous MI 0.81 0.501.34 0.427
both success and failure groups are shown in Table 4. Total Previous CABG 0.74 0.431.05 0.195
in-hospital MACE was low (1.9%) and was slightly higher Unstable angina 0.61 0.361.06 0.084
in the CTO failure group (1.5% vs. 4.4%, p 0.02). The BSA 0.50 0.201.24 0.137
Previous PCI 1.17 0.751.83 0.472
in-hospital mortality was 0.25% and 2.6% in CTO success
In-stent restenosis 1.27 0.652.49 0.478
and failure groups, respectively. The Q-wave MI/non
Absence of side branch 1.96 1.183.26 0.009
Q-wave MI rate was 0.5%/2.5% and 0.8%/1.76% in CTO
Severe tortuosity 2.30 1.264.18 0.006
success and CTO failure groups, respectively. One patient
Moderate calcication 1.95 1.193.21 0.008
in each group needed urgent CABG, and urgent repeat PCI
Severe calcication 1.60 0.972.65 0.064
due to acute vessel closure was seen in 5 (0.6%) cases. Nonaorto-ostial 0.70 0.441.11 0.132
Delayed cardiac tamponade needing pericardiocentesis was Multivessel disease 1.20 0.851.69 0.283
seen in 6 (0.6%) cases. Aortic dissection was seen in 2
BSA body surface area; other abbreviations as in Table 1.
patients, 1 in each group, needing conservative treatment.
JACC: CARDIOVASCULAR INTERVENTIONS, VOL. 2, NO. 6, 2009 Rathore et al. 495
JUNE 2009:489 97 Impact of Novel Guidewire Techniques
abrupt stump in some older studies (8,21). The majority of recommend that PCI should be considered as the preferred
these predictors of unfavorable outcomes were observed strategy for patients who are symptomatic with CTO of the
with antegrade approach to recanalization of the CTO coronary arteries.
lesion, although, this was not observed in our study. Also,
these differences can be explained by increasing use of Reprint requests and correspondence: Dr. Sudhir Rathore,
retrograde and IVUS guided wiring techniques. Department of Cardiology, Toyohashi Heart Center, 21-1, Gobu-
Our study has shown a high incidence of previous MI and dori, Oyama-cho, Toyohashi 441-8530, Japan. E-mail:
previous CABG as reported in literature, but they are not [email protected].
significantly different in patients in the successful and failed
PCI groups.
Comparison of predictors in different studies can be REFERENCES
difficult, as most studies are small (6,8,11,22,23) and some
large series are lacking in angiographic and morphological 1. Christofferson RD, Lehmann KG, Martin GV, Every N, Caldwell JH,
Kapadia SR. Effect of chronic total occlusion on treatment strategy.
characteristics (4,5,12,13). Moreover, the definition of Am J Cardiol 2005;95:1088 91.
CTO varied greatly and the majority of studies including 2. Srinivas VS, Brooks MM, Detre KM, et al. Contemporary percutaneous
patients with 4 weeks duration or longer as well as some coronary intervention versus balloon angioplasty for multivessel coronary
artery disease: a comparison of the National Heart, Lung and Blood
reported studies have included patients of recent occlusions Institute Dynamic Registry and the Bypass Angioplasty Revascularisation
(4,5). This is very important because the results of CTO- Investigation (BARI) study. Circulation 2002;106:162733.
PCI should be compared with identical patient subsets. 3. Hoye A, Van Domburgh RT, Sonnenschein K, Serruys PW. Percu-
taneous coronary intervention for chronic total occlusions: a Thorax-
Duration of occlusion still remains the important predictor centre experience 19922002. Eur Heart J 2005;26:2630 6.
of outcomes following CTO-PCI. 4. Stone GW, Rutherford BD, McConahay DR, et al. Procedural
The CTO-PCI requires special devices, techniques, and outcome of angioplasty for chronic total occlusion: an analysis of 971
lesions in 905 patients. J Am Coll Cardiol 1990;15:849 56.
different strategies. The procedural success mainly depends 5. Bell MR, Berger PB, Bresnahan JF, Reeder GS, Bailey KR, Holmes
on the operators techniques and combination of complex DR Jr. Initial and long term outcome of 354 patients after coronary
strategies. Stepwise utilization of different guidewire strat- balloon angioplasty of total coronary artery occlusions. Circulation
1992;85:100311.
egies is needed in some patients to achieve successful 6. Ruocco NA Jr., Ring ME, Holubkov R, Jacobs AK, Detre KM, Faxon
recanalization. However, there could be an increase in the DP. Results of coronary angioplasty of chronic total occlusions (the
radiation exposure and coronary artery perforation with use National Heart, Lung and Blood Institute 19851986 Percutaneous
Transluminal Coronary Angioplasty Registry). Am J Cardiol 1992;69:
of complex wiring and dedicated CTO guidewires. Further 68 76.
refinement in procedural techniques and education is 7. Ivanhoe RJ, Weintrub WS, Douglas JS Jr., et al. Percutaneous
needed to reduce complications and increase recanalization transluminal coronary angioplasty of chronic total occlusions. Primary
success, restenosis, and long term clinical follow up. Circulation
rates in CTO-PCI. 1992;85:106 15.
Study limitations. The retrospective nature of the study is a 8. Ishizaka N, Issiki T, Saeki F, et al. Angiographic follow up successful
major limitation, and although data was collected prospec- percutaneous coronary angioplasty of chronic total coronary occlusion:
experience of 110 consecutive patients. Am Heart J 1994;127:8 12.
tively, there are limitations to such analysis. Second, the 9. Kinoshita I, Katoh O, Nariyama J, et al. Coronary angioplasty of
duration of occlusion cannot be ascertained with confidence chronic total occlusions with bridging collaterals vessels: immediate and
in some cases. Third, the results of this study could be follow up outcome from a large single-center experience. J Am Coll
Cardiol 1995;26:409 15.
influenced by selection criteria, operator experience, and 10. Suero J, Marso SP, Jones PG, et al. Procedural outcomes and long term
technique variation among the operators. Fourth, lack of survival among patients undergoing percutaneous coronary intervention
follow-up data beyond hospital stay is a limitation. of a chronic total occlusion in native coronary arteries: a 20 year
experience. J Am Coll Cardiol 2001;38:409 14.
11. Noguchi T, Miyazaki S, Morii I, Daikoku S, Goto Y, Nonogi H.
Conclusions Percutaneous transluminal angioplasty of chronic total occlusions.
Determinants of primary success and long term clinical outcome.
Catheter Cardiovasc Interv 2000;49:258 64.
These data represent a large series of consecutive patients 12. Prasad A, Rihal CS, Lennon RJ, Wiste HJ, Singh M, Holmes DR Jr.
treated with PCI of CTO in contemporary fashion involv- Trends in outcomes after percutaneous coronary intervention of
ing dedicated CTO guidewires and novel guidewire cross- chronic total occlusions: a 25 year experience from Mayo clinic. J Am
Coll Cardiol 2007;49:1611 8.
ing techniques. We have reported high overall success rates 13. Olivari Z, Rubartelli P, Pisicone F, et al., on behalf of TOAST-GISE
with low MACE events and other complication rates. We Investigators. Immediate results and one-year clinical outcome after
found that predictors of failed procedures are severe tortu- percutaneous coronary interventions in chronic total occlusions
(TOAST-GISSE). J Am Coll Cardiol 2003;41:1672 8.
osity and moderate-to-severe calcification of the occluded 14. Horisaki T, Surmely JF, Suzuki T. Contact wire technique: a possible
vessel. As previously reported, other angiographic features strategy for parallel wire technique. J Invasive Cardiol 2007;19:
such as multivessel disease, previous CABG, and side E263 4.
15. Ito S, Suzuki T, Ito T, et al. Novel technique using intravascular
branch at the site of occlusion were not found to be ultrasound guided guide wire cross in coronary intervention for un-
predictive of procedural failure in our study. Thus, we crossable chronic total occlusions. Circ J 2004;68:1088 92.
JACC: CARDIOVASCULAR INTERVENTIONS, VOL. 2, NO. 6, 2009 Rathore et al. 497
JUNE 2009:489 97 Impact of Novel Guidewire Techniques
16. Matsubara T, Murata A, Kanyama H, Ogino A. IVUS-guided wiring 21. Tan KH, Sulke N, Taub NA, Watts E, Karani S, Sowton E.
technique: promising approach for the chronic total occlusion. Catheter Determinants of success of coronary angioplasty in patients with a
Cardiovasc Interv 2004;61:381 6. chronic total occlusion. A multiple logistic regression model to improve
17. Surmely JF, Katoh O, Tsuchikane E, Nasu K, Suzuki T. Coronary selection of patients. Br Heart J 1993;70:126 31.
septal collaterals as an access for the retrograde approach in the 22. Safian ED, McCabe CH, Sipperly ME, McKay RG, Baim DS. Intial
percutaneous treatment of coronary chronic total occlusions. Catheter success and long term follow up of percutaneous transluminal coronary
Cardiovasc Interv 2007;69:826 32. angioplasty in chronic total occlusions versus conventional stenosis.
18. Surmely JF, Tsuchikane E, Katoh O, et al. New concept for CTO Am J Cardiol 1988;61:23G 8G.
recanalization using controlled antegrade and retrograde subintimal 23. Hamm CW, Kupper W, Kuck KH, Hofmann D, Bleifeld W.
tracking: the CART technique. J Invasive Cardiol 2006;18:334 8.
Recanalization of chronic, totally occluded arteries by new angioplasty
19. Yang EH, Gumina RJ, Lenon RJ, Holmes DR Jr., Rihal CS, Singh M.
systems. Am J Cardiol 1990;66:1459 63.
Emergency coronary artery bypass surgery for percutaneous coronary
intervention: changes in the incidence, clinical chracteristics, and
indications from 1979 to 2003. J Am Coll Cardoiol 2005;46:2004 9.
20. Grayson AD, Moore RK, Jackson M, et al., on behalf of North West Key Words: chronic total occlusion percutaneous coro-
Quality Improvement Programme in Cardiac Interventions. Multivar- nary intervention in-hospital major adverse cardiac
iate prediction of major adverse cardiac events after 9914 percutaneous
coronary interventions in the north west of England. Heart 2006;92: events procedural success controlled antegrade and
658 63. retrograde tracking.